We recently reported on the development of a novel series of BRAF inhibitors based on a tripartite A-B-C system characterized by a para-substituted central aromatic core connected to an imidazo[4,5]pyridin-2-one scaffold and a substituted urea linker. Here, we present a new series of BRAF inhibitors in which the central phenyl ring connects to the hinge binder and substrate pocket of BRAF with a meta-substitution pattern. The optimization of this new scaffold led to the development of lownanomolar inhibitors that permits the use of a wider range of linkers and terminal C rings while enhancing the selectivity for the BRAF enzyme in comparison to the para series. © 2010 American Chemical Society.

BRAF inhibitors based on an imidazo[4,5]pyridin-2-one scaffold and a meta substituted middle ring / Nourry, Arnaud; Zambon, Alfonso; Davies, Lawrence; Niculescu Duvaz, Ion; Dijkstra, Harmen P.; Ménard, Delphine; Gaulon, Catherine; Niculescu Duvaz, Dan; Suijkerbuijk, Bart M. J. M.; Manne, Frank Friedlos Helen A.; Kirk, Ruth; Whittaker, Steven; Marais, Richard; Springer, Caroline J.. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 53:5(2010), pp. 1964-1978. [10.1021/jm901509a]

BRAF inhibitors based on an imidazo[4,5]pyridin-2-one scaffold and a meta substituted middle ring

ZAMBON, Alfonso;
2010

Abstract

We recently reported on the development of a novel series of BRAF inhibitors based on a tripartite A-B-C system characterized by a para-substituted central aromatic core connected to an imidazo[4,5]pyridin-2-one scaffold and a substituted urea linker. Here, we present a new series of BRAF inhibitors in which the central phenyl ring connects to the hinge binder and substrate pocket of BRAF with a meta-substitution pattern. The optimization of this new scaffold led to the development of lownanomolar inhibitors that permits the use of a wider range of linkers and terminal C rings while enhancing the selectivity for the BRAF enzyme in comparison to the para series. © 2010 American Chemical Society.
2010
53
5
1964
1978
BRAF inhibitors based on an imidazo[4,5]pyridin-2-one scaffold and a meta substituted middle ring / Nourry, Arnaud; Zambon, Alfonso; Davies, Lawrence; Niculescu Duvaz, Ion; Dijkstra, Harmen P.; Ménard, Delphine; Gaulon, Catherine; Niculescu Duvaz, Dan; Suijkerbuijk, Bart M. J. M.; Manne, Frank Friedlos Helen A.; Kirk, Ruth; Whittaker, Steven; Marais, Richard; Springer, Caroline J.. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 53:5(2010), pp. 1964-1978. [10.1021/jm901509a]
Nourry, Arnaud; Zambon, Alfonso; Davies, Lawrence; Niculescu Duvaz, Ion; Dijkstra, Harmen P.; Ménard, Delphine; Gaulon, Catherine; Niculescu Duvaz, Dan; Suijkerbuijk, Bart M. J. M.; Manne, Frank Friedlos Helen A.; Kirk, Ruth; Whittaker, Steven; Marais, Richard; Springer, Caroline J.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1138845
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 22
  • ???jsp.display-item.citation.isi??? 20
social impact